Prognostic heterogeneity in ASXL1-mutated AML and refinement by an immunophenotype-based score

医学 肿瘤科 髓系白血病 内科学 不利影响 队列 总体生存率 髓样 下调和上调 生物信息学 队列研究 预测模型 比例危险模型 白血病 生存分析 靶向治疗 疾病 回顾性队列研究 血液学 观察研究
作者
Yaming Zhang,Min Zhang,Yali Huang,Junzhao Wan,Ping Liu,Ping Wang,Zhen Zhou,Fangya Hu,Jianta Wang,Dan Ma,Qian Kang
出处
期刊:Frontiers in Oncology [Frontiers Media]
卷期号:16: 1780304-1780304
标识
DOI:10.3389/fonc.2026.1780304
摘要

Introduction ASXL1 is a frequently mutated gene in acute myeloid leukemia (AML) and is clinically recognized as an adverse prognostic marker, yet its clinical impact remains markedly heterogeneous. Methods Utilizing the BeatAML cohort, we integrated genomic, transcriptomic, immunophenotypic, and drug-sensitivity data to delineate this variability. Results Although ASXL1 mutations remained an independent adverse factor in multivariable analyses, survival outcomes did not differ significantly between ASXL1 -mutated patients and those lacking other high-risk lesions after excluding co-occurring adverse mutations, suggesting that ASXL1 status alone does not uniformly dictate prognosis. By stratifying ASXL1 -mutated patients based on treatment response, we identified two biologically distinct subsets-complete remission (CR) versus relapsed/refractory (R/R)-characterized by divergent clinical outcomes. Comparative analyses revealed distinct transcriptional profiles, including upregulated MAP3K15 expression in ASXL1 -mutated cases, alongside consistent immunophenotypic downregulation of CD11b, CD123, and HLA-DR in R/R patients. Leveraging these routinely measured markers, we developed a three-parameter ImmuScore that robustly stratified prognosis in both the BeatAML cohort and an independent clinical validation set. Importantly, the ImmuScore captured functional drug-response patterns: patients with low scores displayed significantly higher Z-scores-indicating reduced sensitivity across multiple chemotherapeutic and targeted agents. Discussion These findings link immunophenotypic signatures to therapeutic vulnerability, providing a mechanistic explanation for treatment failure in a subset of ASXL1 -mutated AML. To address potential small-sample bias, Firth penalized regression was applied. Collectively, this study demonstrates that ASXL1 -mutated AML is not a monolithic high-risk entity. The ImmuScore provides a biologically informed and clinically feasible tool to identify truly high-risk ASXL1 -mutated patients, potentially guiding personalized therapeutic strategies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
太极完成签到 ,获得积分10
刚刚
Orange的应助被体重有点陈先生采纳,获得10
1秒前
liko发布了新的文献求助10
1秒前
2秒前
坨坨完成签到,获得积分10
3秒前
3秒前
3秒前
5秒前
5秒前
sm完成签到,获得积分10
5秒前
zhaoshuo发布了新的文献求助10
6秒前
7秒前
7秒前
壮观的凝阳完成签到,获得积分20
8秒前
韩大王发布了新的文献求助10
9秒前
啦啦啦发布了新的文献求助10
9秒前
9秒前
Minnie发布了新的文献求助10
10秒前
10秒前
billc73发布了新的文献求助10
10秒前
英姑的应助被18756828852采纳,获得10
10秒前
10秒前
麦小布完成签到,获得积分10
12秒前
似水流年发布了新的文献求助10
12秒前
13秒前
XYM发布了新的文献求助20
13秒前
顺利盼曼完成签到 ,获得积分10
14秒前
15秒前
体重有点陈先生完成签到,获得积分20
15秒前
33发布了新的文献求助10
15秒前
Chen完成签到,获得积分10
16秒前
vc发布了新的文献求助10
18秒前
充电宝的应助被酷酷的悒采纳,获得10
19秒前
19秒前
Owen的应助被科研通管家采纳,获得10
20秒前
在水一方的应助被科研通管家采纳,获得10
20秒前
John的应助被科研通管家采纳,获得10
20秒前
又又完成签到,获得积分10
20秒前
Maestro_S的应助被科研通管家采纳,获得10
20秒前
小马甲的应助被科研通管家采纳,获得10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192776
求助须知:如何正确求助?哪些是违规求助? 9579206
关于积分的说明 21864151
捐赠科研通 7792348
什么是DOI,文献DOI怎么找? 3437041
关于科研通互助平台的介绍 2560633
邀请新用户注册赠送积分活动 2483916